Zilun Wei

Zilun Wei

Auto-generated profile, based on publicly available information

Zilun Wei

Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China; Institute of Biomedical Science, Fudan University, Shanghai, China; Department of Cardiology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Life Sciences
Verified
Journal Article
Open access
ZWZilun Wei
Zilun Wei
SQShuaihua Qiao
Shuaihua Qiao
JZJinxuan Zhao
Jinxuan Zhao
YLYihai Liu
Yihai Liu
QLQiaoling Li
Qiaoling Li
BXBiao Xu
Biao Xu
The inflammation modulation effects of mesenchymal stromal cell-derived exosomes (MSC-EXO) are well established. We aimed to explore the mechanism behind the inflammatory responses of numerous exosomal cargo molecules that have been neglected in molecular biology research, and to develop an exosomal cargo delivery system that can exert a stronger therapeutic effect on myocardial ischemia-reperfusion (I/R) injury. Computational approaches were used to identify key exosomal miRNAs and their downstream mRNAs that are expressed in the inflammatory response. Direct interactions between miRNA-181a and the c-Fos mRNA complex were confirmed by luciferase reporter assay. MSC-EXO carrying miRNA-181a-overexpressing lentiviruses were intramyocardially injected into a mouse model of myocardial I/R injury. I/R progression was evaluated through echocardiography and immunofluorescence microscopy. miRNA-181a provided substantial coverage against a host of immune-related genes through the miRNA-mRNA network. miRNA-181a delivery by MSC-EXO combined the immune-suppressing effect of miRNA-181a and the cell targeting capability of MSC-EXO to exert a stronger therapeutic effect on myocardium I/R injury. We showed the potential of MSC-EXO as a tool for the specific delivery of small RNAs in vivo. This study shed new light on the potential application of miRNA-181a-overexpressing MSC-EXO as a therapeutic strategy for myocardial I/R injury.

1 August 2021 in Biomaterials
Verified
Journal Article
Closed access
ZWZilun Wei
Zilun Wei
ZCZhaoyang Chen
Zhaoyang Chen
YZYongchao Zhao
Yongchao Zhao
FFFan Fan
Fan Fan
WXWeidong Xiong
Weidong Xiong
JGJunbo Ge
Junbo Ge

1 September 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XSXuan Sun
Xuan Sun
ASAnqi Shan
Anqi Shan
ZWZilun Wei
Zilun Wei
BXBiao Xu
Biao Xu

13 January 2020 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
XSXuan Sun
Xuan Sun
ZWZilun Wei
Zilun Wei
YLYuyu Li
Yuyu Li
JWJunzhuo Wang
Junzhuo Wang
JHJiaxin Hu
Jiaxin Hu
BXBiao Xu
Biao Xu

9 April 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
ZWZilun Wei
Zilun Wei
YLYihai Liu
Yihai Liu
SQShuaihua Qiao
Shuaihua Qiao
XLXueling Li
Xueling Li
QLQiaoling Li
Qiaoling Li
BXBiao Xu
Biao Xu
Hepatocellular carcinoma (HCC) ranks the third major cause of cancer‑associated mortality globally. Numerous studies have attempted to elucidate the underlying mechanisms of HCC using various biomarkers. In the present study, two expression profiles datasets from Gene Expression Omnibus (GSE76427 and GSE84402) and data associated with liver cancer samples from The Cancer Genome Atlas (TCGA) were downloaded for integrated analysis. Five differentially expressed genes (DEGs) exhibiting high expression, including ubiquitin‑conjugating enzyme 2C (UBE2C), topoisomerase II α, pituitary tumor transforming gene 1, glypican‑3 and polycomb‑repressive complex 1, were selected and considered as candidate genes. Enrichment analysis demonstrated that these genes were associated with Gene Ontology terms of cellular components and molecular functions, including regulation of apoptosis, stabilization of p53 and Anaphase Promoting Complex/Cyclosome (APC/C) (APC/C:Cdc20)‑mediated degradation of Securin. The expression profiles of these genes in HCC, other human malignancies and different human HCC cell lines were validated using GSE14520, GSE3500 and TCGA data. The results confirmed the upregulation of UBE2C in tissues from patients with HCC or other human malignancies and human liver cancer cell lines, compared with the expression levels in the corresponding adjacent non‑tumor tissues and cell lines, respectively. Patients with HCC who exhibited an increased messenger RNA level of UBE2C exhibited a significantly shorter survival time. The results of the present study suggest that the overexpression of UBE2C may be used as a novel prognostic biomarker of HCC.

1 July 2021 in Genes & Diseases
Verified
Journal Article
Open access
ZWZilun Wei
Zilun Wei
YYYining Yang
Yining Yang
QLQiaoling Li
Qiaoling Li
YYYong Yin
Yong Yin
ZWZhonghai Wei
Zhonghai Wei
BXBiao Xu
Biao Xu
Hypertension (HT) is the most common public-health challenge and shows a high incidence around the world. Cardiovascular diseases are the leading cause of mortality and morbidity among the elderly (age > 65 years) in the United States. Now, there is widespread acceptance of the causal link between HT and acute myocardial infarction (MI). This is the first data-mining study to identify co-expressed differentially expressed genes (co-DEGs) between HT and MI (relative to normal control) and to uncover potential biomarkers and therapeutic targets of HT-related MI. In this manuscript, HT-specific DEGs and MI-specific DEGs and differentially expressed microRNAs (DE-miRNAs) were identified in Gene Expression Omnibus (GEO) datasets GSE24752, GSE60993, GSE62646, and GSE24548 after data consolidation and batch correction. Subsequently, enrichment in Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways as well as protein–protein interaction networks were identified, and single-gene gene set enrichment analysis was performed to determine the affected biological categories and networks. Cross-matching of the results on co-DE-miRNAs and predicted miRNAs targeting the co-DEGs was conducted and discussed as well. We found that MYC and HIST1H2BO may be associated with HT, whereas FCGR1A, FYN, KLRD1, KLRB1, and FOLR3 may be implicated in MI. Moreover, co-DEGs FOLR3 and NFE2 with predicted miRNAs and DE-miRNAs, especially miR-7 and miR-548, may be significantly associated and show huge potential as a new set of novel biomarkers and important molecular targets in the course of HT-related MI.